Stay updated on TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial
Sign up to get notified when there's something new on the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page.

Latest updates to the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page
- Check4 days agoChange DetectedA new site revision (v3.4.3) was added and the previous revision (v3.4.2) removed, indicating a routine version update.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.4.2 is now displayed; the older v3.4.1 funding/operating status notice has been removed.SummaryDifference0.4%

- Check40 days agoChange DetectedA site-wide notice about government funding status and NIH Clinical Center operations was added, and the revision label updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check47 days agoChange DetectedGlossary visibility option added. QC-related labels and FEAR Act data wording updated, and the site version updated to v3.4.0 (from v3.3.4).SummaryDifference0.2%

- Check61 days agoChange DetectedThe page shows a minor version update from v3.3.3 to v3.3.4 with no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a Locations section with Liaoning (China) and removed the old Liaoning Locations entry, with the page revision updated to v3.3.3 and the HHS Vulnerability Disclosure link removed.SummaryDifference0.2%

Stay in the know with updates to TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page.